Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa
View ORCID ProfileShabir A. Madhi, View ORCID ProfileVicky Baillie, View ORCID ProfileClare L. Cutland, Merryn Voysey, Anthonet L. Koen, View ORCID ProfileLee Fairlie, Sherman D. Padayachee, View ORCID ProfileKeertan Dheda, View ORCID ProfileShaun L. Barnabas, View ORCID ProfileQasim Ebrahim Bhorat, View ORCID ProfileCarmen Briner, Gaurav Kwatra, NGS-SA, Wits-VIDA COVID team, View ORCID ProfileKhatija Ahmed, Parvinder Aley, Sutika Bhikha, Jinal N. Bhiman, As’ad Ebrahim Bhorat, Jeanine du Plessis, View ORCID ProfileAliasgar Esmail, Marisa Groenewald, View ORCID ProfileElizea Horne, Shi-Hsia Hwa, Aylin Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Masebole Masenya, Mduduzi Masilela, Shakeel McKenzie, Kgaogelo Molapo, Andrew Moultrie, View ORCID ProfileSuzette Oelofse, View ORCID ProfileFaeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Lindie Rossouw, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Samuel van Eck, Constantinos Kurt Wibmer, Nicholas M. Durham, Elizabeth J Kelly, Tonya L Villafana, Sarah Gilbert, Andrew J Pollard, View ORCID ProfileTulio de Oliveira, View ORCID ProfilePenny L. Moore, Alex Sigal, Alane Izu
doi: https://doi.org/10.1101/2021.02.10.21251247
Shabir A. Madhi
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
2Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
PhDVicky Baillie
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
2Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
PhDClare L. Cutland
3African Leadership in Vaccinology Expertise, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
PhDMerryn Voysey
4Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
DPhilAnthonet L. Koen
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
2Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
MBBChLee Fairlie
5Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
FCPaedsSherman D. Padayachee
6Setshaba Research Centre, Tshwane, South Africa
MBChBKeertan Dheda
7Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, South Africa Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK
PhDShaun L. Barnabas
8Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa
PhDQasim Ebrahim Bhorat
9Soweto Clinical Trials Centre, Soweto, South Africa
MScCarmen Briner
10Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBBChGaurav Kwatra
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
2Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
PhD11Network for Genomic Surveillance in South Africa (NGS-SA) group
12Wits VIDA COVID vaccine trial group
Khatija Ahmed
6Setshaba Research Centre, Tshwane, South Africa
FCPath (Micro)Parvinder Aley
4Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
DPhilSutika Bhikha
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
2Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
MBBChJinal N. Bhiman
15National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
16Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
PhDAs’ad Ebrahim Bhorat
9Soweto Clinical Trials Centre, Soweto, South Africa
FRACGPJeanine du Plessis
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Aliasgar Esmail
7Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, South Africa Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK
MDMarisa Groenewald
8Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa
MBBCHElizea Horne
5Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBBCHShi-Hsia Hwa
17Africa Health Research Institute, Durban, South Africa
19Division of Infection and Immunity, University College London, London, UK
MScAylin Jose
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
Teresa Lambe
14Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK
PhDMatt Laubscher
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MScMookho Malahleha
6Setshaba Research Centre, Tshwane, South Africa
MBChBMasebole Masenya
5Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBChBMduduzi Masilela
6Setshaba Research Centre, Tshwane, South Africa
MBChBShakeel McKenzie
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
BScKgaogelo Molapo
6Setshaba Research Centre, Tshwane, South Africa
Andrew Moultrie
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
BSc HonsSuzette Oelofse
7Division of Pulmonology, Groote Schuur Hospital and the University of Cape Town, South Africa Faculty of Infectious and Tropical Diseases, Department of Immunology and Infection, London School of Hygiene and Tropical Medicine, London, UK
MBChBFaeezah Patel
5Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBBChSureshnee Pillay
20KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban South Africa
Sarah Rhead
4Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
MBChBHylton Rodel
17Africa Health Research Institute, Durban, South Africa
19Division of Infection and Immunity, University College London, London, UK
BScLindie Rossouw
8Family Centre for Research with Ubuntu, Department of Paediatrics, University of Stellenbosch, Cape Town, South Africa
MBBCHCarol Taoushanis
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
BPharmHouriiyah Tegally
20KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban South Africa
Asha Thombrayil
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
MBBChSamuel van Eck
5Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
RNConstantinos Kurt Wibmer
15National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
16Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
PhDNicholas M. Durham
13Astra Zeneca Biopharmaceuticals, Cambridge, UK
Elizabeth J Kelly
13Astra Zeneca Biopharmaceuticals, Cambridge, UK
Tonya L Villafana
13Astra Zeneca Biopharmaceuticals, Cambridge, UK
PhDSarah Gilbert
14Jenner Institute, Nuffield Department of Medicine, University of Oxford, UK
PhDAndrew J Pollard
4Oxford Vaccine Group, Department of Paediatrics, University of Oxford, UK
FMedSciTulio de Oliveira
20KwaZulu-Natal Research and Innovation Sequencing Platform (KRISP), University of KwaZulu-Natal, Durban South Africa
PhDPenny L. Moore
15National Institute for Communicable Diseases (NICD) of the National Health Laboratory Service (NHLS), Johannesburg, South Africa
16Antibody Immunity Research Unit, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
PhDAlex Sigal
17Africa Health Research Institute, Durban, South Africa
18Max Planck Institute for Infection Biology, Berlin, Germany
PhDAlane Izu
1South African Medical Research Council Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa
2Department of Science and Innovation/National Research Foundation South African Research Chair Initiative in Vaccine Preventable Diseases Unit, University of the Witwatersrand, Johannesburg, South Africa
PhD
- Supplemental text_SA_VE[supplements/251247_file03.pdf]
Posted February 12, 2021.
Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa
Shabir A. Madhi, Vicky Baillie, Clare L. Cutland, Merryn Voysey, Anthonet L. Koen, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Gaurav Kwatra, NGS-SA, Wits-VIDA COVID team, Khatija Ahmed, Parvinder Aley, Sutika Bhikha, Jinal N. Bhiman, As’ad Ebrahim Bhorat, Jeanine du Plessis, Aliasgar Esmail, Marisa Groenewald, Elizea Horne, Shi-Hsia Hwa, Aylin Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Masebole Masenya, Mduduzi Masilela, Shakeel McKenzie, Kgaogelo Molapo, Andrew Moultrie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Lindie Rossouw, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Samuel van Eck, Constantinos Kurt Wibmer, Nicholas M. Durham, Elizabeth J Kelly, Tonya L Villafana, Sarah Gilbert, Andrew J Pollard, Tulio de Oliveira, Penny L. Moore, Alex Sigal, Alane Izu
medRxiv 2021.02.10.21251247; doi: https://doi.org/10.1101/2021.02.10.21251247
Safety and efficacy of the ChAdOx1 nCoV-19 (AZD1222) Covid-19 vaccine against the B.1.351 variant in South Africa
Shabir A. Madhi, Vicky Baillie, Clare L. Cutland, Merryn Voysey, Anthonet L. Koen, Lee Fairlie, Sherman D. Padayachee, Keertan Dheda, Shaun L. Barnabas, Qasim Ebrahim Bhorat, Carmen Briner, Gaurav Kwatra, NGS-SA, Wits-VIDA COVID team, Khatija Ahmed, Parvinder Aley, Sutika Bhikha, Jinal N. Bhiman, As’ad Ebrahim Bhorat, Jeanine du Plessis, Aliasgar Esmail, Marisa Groenewald, Elizea Horne, Shi-Hsia Hwa, Aylin Jose, Teresa Lambe, Matt Laubscher, Mookho Malahleha, Masebole Masenya, Mduduzi Masilela, Shakeel McKenzie, Kgaogelo Molapo, Andrew Moultrie, Suzette Oelofse, Faeezah Patel, Sureshnee Pillay, Sarah Rhead, Hylton Rodel, Lindie Rossouw, Carol Taoushanis, Houriiyah Tegally, Asha Thombrayil, Samuel van Eck, Constantinos Kurt Wibmer, Nicholas M. Durham, Elizabeth J Kelly, Tonya L Villafana, Sarah Gilbert, Andrew J Pollard, Tulio de Oliveira, Penny L. Moore, Alex Sigal, Alane Izu
medRxiv 2021.02.10.21251247; doi: https://doi.org/10.1101/2021.02.10.21251247
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)